Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitorsRosanna Maccari, Rosaria Ottanà, Valerij Talagayev et al.|European Journal of Medicinal Chemistry|2023Cited by 13
Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitorsRosanna Maccari, Rosaria Ottanà, Gerhard Wolber et al.|SSRN Electronic Journal|2023Cited by 0